Treace director gets 30,000 RSUs

Berry Lance A reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Berry Lance A reported acquisition or exercise transactions in this Form 4 filing.

Treace Medical Concepts director Lance A. Berry received an equity grant in the form of restricted stock units. He was awarded 30,000 RSUs tied to the company’s common stock, with each unit convertible into one share upon vesting. These RSUs will vest 100% on the earlier of May 19, 2027 or the 2027 annual meeting of stockholders, as long as he continues serving the company through that date. Berry has elected to defer delivery of the underlying shares until the earlier of a change in control or his separation of service. Following this grant, his direct holdings total 74,593 shares, including the 30,000 RSUs.

Insider Trade Summary

Grant/Award: 30,000 shares

Grant/Award 1 txn

Insider Berry Lance A

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	30,000	$0.00	$0.00

Holdings After Transaction: Common Stock — 74,593 shares (Direct)

Footnotes (2)

1. F1. Represents restricted stock units (RSUs) for which the Reporting Person is entitled to receive one (1) share of Issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on the earlier of (a) May 19, 2027 or (b) the date of the 2027 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through the vesting date. The Reporting Person voluntarily elected to defer receipt of the shares of the Issuer's Common Stock issuable upon settlement of the RSUs until the earlier of a change in control or the Reporting Person's separation of service to the Issuer.
2. F2. Includes 30,000 restricted stock units.

Key Figures

RSU grant size: 30,000 RSUs Vesting date: May 19, 2027 Post-transaction holdings: 74,593 shares +1 more

4 metrics

RSU grant size 30,000 RSUs Award of restricted stock units to director Lance A. Berry

Vesting date May 19, 2027 RSUs vest on earlier of this date or 2027 annual meeting

Post-transaction holdings 74,593 shares Total direct holdings after RSU grant, including 30,000 RSUs

Grant price per share $0.0000 per share Indicates compensation-related RSU award, not open-market purchase

Key Terms

restricted stock units (RSUs), change in control, separation of service, annual meeting of stockholders

4 terms

restricted stock units (RSUs) financial

"Represents restricted stock units (RSUs) for which the Reporting Person is entitled to receive one (1) share..."

Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.

change in control financial

"until the earlier of a change in control or the Reporting Person's separation of service..."

A "change in control" occurs when the ownership or management of a company shifts significantly, such as through a merger, acquisition, or sale of a large part of its assets. This change can impact how the company is run and may influence its future direction. For investors, it matters because it can affect the company's stability, strategy, and value, often signaling potential changes in investment risk or opportunity.

separation of service financial

"until the earlier of a change in control or the Reporting Person's separation of service..."

annual meeting of stockholders financial

"the earlier of (a) May 19, 2027 or (b) the date of the 2027 annual meeting of stockholders..."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Treace Medical Concepts (TMCI) report for Lance A. Berry?

Treace Medical Concepts reported that director Lance A. Berry received a grant of 30,000 restricted stock units. Each RSU represents the right to receive one share of common stock upon vesting, as part of his equity-based compensation package.

When do Lance A. Berry’s 30,000 TMCI restricted stock units vest?

The 30,000 restricted stock units will be 100% vested on the earlier of May 19, 2027 or the 2027 annual meeting of stockholders. Vesting is contingent on Berry continuing to provide service to Treace Medical Concepts through that vesting date.

How many Treace Medical Concepts (TMCI) shares does Lance A. Berry hold after this Form 4 transaction?

After the grant, Lance A. Berry’s direct holdings total 74,593 shares of Treace Medical Concepts common stock. This amount includes the 30,000 restricted stock units disclosed, which convert into shares when they vest and settle under the award terms.

Did Lance A. Berry pay cash for the 30,000 TMCI restricted stock units?

No cash purchase was involved; the Form 4 shows the 30,000 restricted stock units with a price of $0.0000 per share. This indicates a compensation-related award rather than an open-market buy of Treace Medical Concepts stock.

How will Lance A. Berry receive shares from his Treace Medical Concepts RSUs?

Berry voluntarily elected to defer receipt of the common shares issuable upon settlement of the RSUs. He will receive the shares at the earlier of a change in control of Treace Medical Concepts or his separation of service from the company.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/19/2026 - 09:00 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Berry Lance A

(Last) (First) (Middle)

C/O TREACE MEDICAL CONCEPTS, INC.

100 PALMETTO PARK PLACE

(Street)

PONTE VEDRA FLORIDA 32081

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
TREACE MEDICAL CONCEPTS, INC. [ TMCI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/19/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/19/2026		A		30,000(1)	A	$0	74,593(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted stock units (RSUs) for which the Reporting Person is entitled to receive one (1) share of Issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on the earlier of (a) May 19, 2027 or (b) the date of the 2027 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through the vesting date. The Reporting Person voluntarily elected to defer receipt of the shares of the Issuer's Common Stock issuable upon settlement of the RSUs until the earlier of a change in control or the Reporting Person's separation of service to the Issuer.

2. Includes 30,000 restricted stock units.

	/s/ Lisa Taylor as Attorney-in-fact for Lance A. Berry	05/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)